Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
Willekens G, Studt JD, Mendez A, Alberio L, Fontana P, Wuillemin WA, Schmidt A, Graf L, Gerber B, Bovet C, Sauter TC, Nagler M. Willekens G, et al. Among authors: studt jd. Br J Haematol. 2021 Jun;193(6):1203-1212. doi: 10.1111/bjh.17470. Epub 2021 May 6. Br J Haematol. 2021. PMID: 33954979 Free PMC article. Clinical Trial.
Thrombotic thrombocytopenic purpura.
Lämmle B, Kremer Hovinga J, Studt JD, Mansouri Taleghani B, Alberio L. Lämmle B, et al. Among authors: studt jd. Hematol J. 2004;5 Suppl 3:S6-11. doi: 10.1038/sj.thj.6200413. Hematol J. 2004. PMID: 15190269 Review. No abstract available.
Impact of rivaroxaban on point-of-care assays.
Fontana P, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Schmid P, Stricker H, Studt JD, Tsakiris DA, Wuillemin WA, Nagler M. Fontana P, et al. Among authors: studt jd. Thromb Res. 2017 May;153:65-70. doi: 10.1016/j.thromres.2017.03.019. Epub 2017 Mar 21. Thromb Res. 2017. PMID: 28343143 Clinical Trial.
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, Hegemann I, Korte W, Kremer Hovinga J, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris D, Wuillemin W, Asmis L. Casini A, et al. Among authors: studt jd. Swiss Med Wkly. 2020 Apr 11;150:w20247. doi: 10.4414/smw.2020.20247. eCollection 2020 Apr 6. Swiss Med Wkly. 2020. PMID: 32277760 Free article. No abstract available.
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.
Alberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin W. Alberio L, et al. Among authors: studt jd. Swiss Med Wkly. 2020 Apr 24;150:w20210. doi: 10.4414/smw.2020.20210. eCollection 2020 Apr 20. Swiss Med Wkly. 2020. PMID: 32329806 Free article.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
Fontana P, Alberio L, Albisetti M, Angelillo-Scherrer A, Asmis LM, Casini A, Gerber B, Graf L, Hegemann I, Korte W, Martinez M, Studt JD, Tsakiris DA, Wuillemin WA, Kremer Hovinga JA. Fontana P, et al. Among authors: studt jd. Swiss Med Wkly. 2020 Dec 18;150:w20422. doi: 10.4414/smw.2020.20422. eCollection 2020 Dec 14. Swiss Med Wkly. 2020. PMID: 33338252 Free article.
72 results